Skip to main content

Sacubitril / valsartan News

Entresto Granted Expanded Indication in Chronic Heart Failure by FDA

EAST HANOVER, N.J., Feb. 16, 2021 -- Novartis today announced that the US Food and Drug Administration (FDA) has approved the following expanded indication for Entresto® (sacubitril/valsartan): to red...

FDA Approves Entresto (sacubitril/valsartan) for Pediatric Heart Failure

East Hanover, N.J., Oct. 1, 2019 – Novartis announced today that the U.S. Food and Drug Administration (FDA) has approved Entresto (sacubitril/valsartan) for the treatment of symptomatic heart f...

FDA Approves Entresto (sacubitril/valsartan) for Heart Failure

July 7, 2015 – The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Heart Failure, Congestive Heart Failure

Related drug support groups

Entresto

Sacubitril / valsartan patient information at Drugs.com